Full View

Plasma metabolomics implicates modified transfer RNAs and altered bioenergetics in the outcomes of pulmonary arterial hypertension

CJ Rhodes, P Ghataorhe, J Wharton… - Circulation, 2017 - Am Heart Assoc
Background: Pulmonary arterial hypertension (PAH) is a heterogeneous disorder with high
mortality. Methods: We conducted a comprehensive study of plasma metabolites using …
被引用次数：185 相关文章

Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension

CJ Rhodes, P Ghataorhe, J Wharton, KC Rue-Albrecht… - Circulation, 2017 - cir.nii.ac.jp
< jats: sec>< jats: title> Background:</jats: title>< jats: p> Pulmonary arterial hypertension
(PAH) is a heterogeneous disorder with high mortality.</jats: p></jats: sec>< jats: sec>< jats …
[HTML] nih.gov

[HTML][HTML] Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension

CJ Rhodes, P Ghataorhe, J Wharton… - Circulation, 2017 - ncbi.nlm.nih.gov
BACKGROUND: Pulmonary arterial hypertension (PAH) is a heterogeneous disorder with
high mortality. METHODS: We conducted a comprehensive study of plasma metabolites …

Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension

CJ Rhodes, P Ghataorhe, J Wharton… - …, 2017 - ingentaconnect.com
Background: Pulmonary arterial hypertension (PAH) is a heterogeneous disorder with high
mortality. Methods: We conducted a comprehensive study of plasma metabolites using …

Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension.

CJ Rhodes, P Ghataorhe, J Wharton, KC Rue-Albrecht… - 2017 - repository.cam.ac.uk
BACKGROUND: Pulmonary arterial hypertension (PAH) is a heterogeneous disorder with
high mortality. METHODS: We conducted a comprehensive study of plasma metabolites …
[PDF] core.ac.uk

[PDF][PDF] Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension

CJ Rhodes, P Ghataorhe, J Wharton, KC Rue-Albrecht… - Circulation, 2017 - core.ac.uk
BACKGROUND: Pulmonary arterial hypertension (PAH) is a heterogeneous disorder with
high mortality. METHODS: We conducted a comprehensive study of plasma metabolites …

Plasma metabolomics implicates modified transfer RNAs and altered bioenergetics in the outcomes of pulmonary arterial hypertension

CJ Rhodes, P Ghataorhe, J Wharton, KC Rue-Albrecht… - Circulation, 2016 - ora.ox.ac.uk
Background: Pulmonary arterial hypertension (PAH) is a heterogeneous disorder with high
mortality. Methods: We conducted a comprehensive study of plasma metabolites using …
[PDF] researchgate.net

[PDF][PDF] Plasma Metabolomics Implicate Modified Transfer RNAs and Altered Bioenergetics in the Outcome of Pulmonary Arterial Hypertension

H Campus - researchgate.net
Background—Pulmonary arterial hypertension (PAH) is a heterogeneous disorder with high
mortality. Methods—We conducted a comprehensive study of plasma metabolites using ultra …

Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension

CJ Rhodes, P Ghataorhe, J Wharton… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Pulmonary arterial hypertension (PAH) is a heterogeneous disorder with high
mortality. Methods We conducted a comprehensive study of plasma metabolites using …

Plasma Metabolomics Implicate Modified Transfer RNAs and Altered Bioenergetics in the Outcome of Pulmonary Arterial Hypertension.

CJ Rhodes, P Ghataorhe, J Wharton… - …, 2017 - eprints.whiterose.ac.uk
BACKGROUND:-Pulmonary arterial hypertension (PAH) is a heterogeneous disorder with
high mortality. METHODS:-We conducted a comprehensive study of plasma metabolites …